GANDERTON, DAVID,MAIN, MARK JONATHAN,MORGAN, FRAZER GILES
申请号：
NZ58462208
公开号：
NZ584622A
申请日:
2008.10.31
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is the use of a composition of apomorphine and magnesium stearate for preventing or treating the symptoms of Parkinson's disease, wherein the composition is for pulmonary inhalation and comprises a Nominal Dose of apomorphine of at least 0.8 mg and up to 11.5 mg providing a fine particle dose in the order of 0.5 mg to 7 mg.
